AbbVie Inc. vs Gilead Sciences, Inc.
Side-by-side stock comparison based on AI earnings call analysis
| Metric | AbbVie Inc. | Gilead Sciences, Inc. |
|---|---|---|
| Current Price | ₹218.63 | ₹136.22 |
| Market Cap | ₹3.86 L Cr. | ₹1.69 L Cr. |
| Industry | Biotechnology | Biotechnology |
| P/E Ratio | 103.960976 | 18.169836 |
| ROE (%) | — | — |
| Debt/Equity | — | — |
| Sales Growth 5Y (%) | — | — |
| Profit Growth 5Y (%) | — | — |
| Promoter Holding (%) | — | — |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |